124 related articles for article (PubMed ID: 18235260)
1. Re: Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
Sakellaridis NE
Neurosurgery; 2005 Mar; 56(3):E629; author reply E629. PubMed ID: 18235260
[No Abstract] [Full Text] [Related]
2. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
Abosch A; Kapur S; Lang AE; Hussey D; Sime E; Miyasaki J; Houle S; Lozano AM
Neurosurgery; 2003 Nov; 53(5):1095-102; discussion 1102-5. PubMed ID: 14580276
[TBL] [Abstract][Full Text] [Related]
3. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
Thobois S; Fraix V; Savasta M; Costes N; Pollak P; Mertens P; Koudsie A; Le Bars D; Benabid AL; Broussolle E
J Neurol; 2003 Oct; 250(10):1219-23. PubMed ID: 14586606
[TBL] [Abstract][Full Text] [Related]
4. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans.
Hilker R; Voges J; Ghaemi M; Lehrke R; Rudolf J; Koulousakis A; Herholz K; Wienhard K; Sturm V; Heiss WD
Mov Disord; 2003 Jan; 18(1):41-8. PubMed ID: 12518299
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease.
Strafella AP; Sadikot AF; Dagher A
Neuroreport; 2003 Jul; 14(9):1287-9. PubMed ID: 12824777
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report.
Lezcano E; Gómez-Esteban JC; Zarranz JJ; Alcaraz R; Atarés B; Bilbao G; Garibi J; Lambarri I
Mov Disord; 2004 Aug; 19(8):973-7. PubMed ID: 15300669
[TBL] [Abstract][Full Text] [Related]
8. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET.
Hilker R; Voges J; Thiel A; Ghaemi M; Herholz K; Sturm V; Heiss WD
J Neural Transm (Vienna); 2002 Oct; 109(10):1257-64. PubMed ID: 12373559
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
Sakellaridis NE
Neurosurgery; 2005 Apr; 56(4):E873; author reply E873. PubMed ID: 15818885
[No Abstract] [Full Text] [Related]
10. Effect of subthalamic nucleus stimulation during exercise on the mesolimbocortical dopaminergic region in Parkinson's disease: a positron emission tomography study.
Nozaki T; Sugiyama K; Yagi S; Yoshikawa E; Kanno T; Asakawa T; Ito T; Terada T; Namba H; Ouchi Y
J Cereb Blood Flow Metab; 2013 Mar; 33(3):415-21. PubMed ID: 23211966
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptors set the pattern of activity generated in subthalamic neurons.
Baufreton J; Zhu ZT; Garret M; Bioulac B; Johnson SW; Taupignon AI
FASEB J; 2005 Nov; 19(13):1771-7. PubMed ID: 16260646
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of nigrostriatal denervation in basal ganglia.
Hirsch EC; Périer C; Orieux G; François C; Féger J; Yelnik J; Vila M; Levy R; Tolosa ES; Marin C; Trinidad Herrero M; Obeso JA; Agid Y
Trends Neurosci; 2000 Oct; 23(10 Suppl):S78-85. PubMed ID: 11052224
[TBL] [Abstract][Full Text] [Related]
13. 300-Hz subthalamic oscillations in Parkinson's disease.
Foffani G; Priori A; Egidi M; Rampini P; Tamma F; Caputo E; Moxon KA; Cerutti S; Barbieri S
Brain; 2003 Oct; 126(Pt 10):2153-63. PubMed ID: 12937087
[TBL] [Abstract][Full Text] [Related]
14. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study.
Ouchi Y; Yoshikawa E; Futatsubashi M; Okada H; Torizuka T; Sakamoto M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):746-52. PubMed ID: 12045673
[TBL] [Abstract][Full Text] [Related]
15. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
Thobois S; Vingerhoets F; Fraix V; Xie-Brustolin J; Mollion H; Costes N; Mertens P; Benabid AL; Pollak P; Broussolle E
Arch Neurol; 2004 Nov; 61(11):1705-9. PubMed ID: 15534182
[TBL] [Abstract][Full Text] [Related]
16. Endogenous dopamine release after pharmacological challenges in Parkinson's disease.
Piccini P; Pavese N; Brooks DJ
Ann Neurol; 2003 May; 53(5):647-53. PubMed ID: 12730999
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease.
Kane A; Hutchison WD; Hodaie M; Lozano AM; Dostrovsky JO
Neuroreport; 2009 Nov; 20(17):1549-53. PubMed ID: 19829159
[TBL] [Abstract][Full Text] [Related]
18. Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
Chassain C; Melon C; Salin P; Vitale F; Couraud S; Durif F; Kerkerian-Le Goff L; Gubellini P
J Neurochem; 2016 Mar; 136(5):1004-16. PubMed ID: 26576509
[TBL] [Abstract][Full Text] [Related]
19. Disease process and drug treatments in Parkinson's disease.
Leenders KL
Eur Neuropsychopharmacol; 2002 Dec; 12(6):575-80. PubMed ID: 12468020
[No Abstract] [Full Text] [Related]
20. Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study.
Goerendt IK; Messa C; Lawrence AD; Grasby PM; Piccini P; Brooks DJ;
Brain; 2003 Feb; 126(Pt 2):312-25. PubMed ID: 12538400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
